- Open Access
Intervention programs to increase influenza vaccination in Israel: which is the preferred one?
© Grotto and Grefat; licensee BioMed Central Ltd. 2014
- Received: 17 May 2014
- Accepted: 18 May 2014
- Published: 27 May 2014
Influenza vaccine is the most effective method of preventing influenza and its complications, but coverage rates are not satisfactory. Therefore, an effective intervention is required to increase vaccination coverage. In a recent study published in IJHPR, Yamin et al. identified the need to target risk perception in the public, as a major intervention tool. Risk perception and compliance with vaccination guidelines was found to be mostly influenced by physician recommendations. These findings are in-line with similar findings in the literature, stressing the importance of patient-physician interaction in the patients’ decision to comply with vaccination guidelines produced by the public health authorities. They also underscore the need to involve primary physicians in both the decision making process as well in the vaccination campaign.
- Rota Virus
- Risk Perception
- Influenza Vaccine
- Vaccination Coverage
Prof. Itamar Grotto is the Director of the Public Health Services in the Israel Ministry of Health and an associate professor at the Ben-Gurion University of the Negev.
Dr. Rami Grefat is a Public Health Physician in the Haifa District Health Office of the Israel Ministry of Health.
- Warren-Gash C, Smeeth L, Hayward AC: Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009, 9: 601-610. 10.1016/S1473-3099(09)70233-6.View ArticlePubMedGoogle Scholar
- Yamin D, Gavious A, Davidovitch N, Pliskin J: Role of intervention programs to increase influenza vaccination in Israel. Isr J Health Policy Res. 2014, 3: 13-10.1186/2045-4015-3-13.PubMed CentralView ArticlePubMedGoogle Scholar
- Velan B, Boyko V, Lerner-Geva L, Ziv A, Yagar Y, Kaplan G: Individualism, acceptance and differentiation as attitude traits in the public’s response to vaccination. Hum Vaccin Immunother. 2012, 8: 1272-1282.PubMed CentralView ArticlePubMedGoogle Scholar
- Velan B, Boyko V, Shenhar G, Lerner-Geva L, Kaplan G: Analysis of public responses to preparedness policies: the cases of H1N1 influenza vaccination and gas mask distribution. Isr J Health Policy Res. 2013, 2: 11-10.1186/2045-4015-2-11.PubMed CentralView ArticlePubMedGoogle Scholar
- Rossmann Beel E, Rench MA, Montesinos DP, Healy CM: Acceptability of immunization in adult contacts of infants: Possibility of expanding platforms to increase adult vaccine uptake. Vaccine. 2014, 32: 2540-2505. 10.1016/j.vaccine.2014.03.056.View ArticlePubMedGoogle Scholar
- Buyuktiryaki B, Soyer OU, Erkocoglu M, Dogan A, Azkur D, Kocabas CN, Dallar Y, Tuncer A, Sekerel BE: What a pandemic teaches us about vaccination attitudes of parents of children with asthma. Vaccine. 2014, 32: 2275-2280. 10.1016/j.vaccine.2014.02.076.View ArticlePubMedGoogle Scholar
- Zimet GD: Health care professionals and adolescent vaccination: A call for intervention research. Hum Vaccin Immunother. 2014, 10: [Epub ahead of print]Google Scholar
- Kaliner E(1), Moran-Gilad J, Grotto I, Somekh E, Kopel E, Gdalevich M, Shimron E, Amikam Y, Leventhal A, Lev B, Gamzu R: Silent reintroduction of wild-type poliovirus to Israel, 2013 - risk communication challenges in an argumentative atmosphere. Euro Surveill. 2014, 19: 20703.View ArticlePubMedGoogle Scholar
- Pitman RJ, Nagy LD, Sculpher MJ: Cost-effectiveness of childhood influenza vaccination in England and Wales: results from a dynamic transmission model. Vaccine. 2013, 31: 927-942. 10.1016/j.vaccine.2012.12.010.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.